We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Second quarter results 2023
July 18, 2023 | Basel, Switzerland
Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Condensed financial report (PDF 0.3 MB)
Download the interactive presentation (PDF 3.4 MB)
Download the podcast (MP3 34 MB)
Novartis Q2 2023 Impact and Sustainability Update (PDF 0.3 MB)
Investors Event Calendar
View recent presentations and learn more about upcoming events.
October 24, 2023
Third quarter & Nine months 2023 results
Basel, Switzerland
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG Updates: May 03, 2023 (PDF 1.9 MB) | Feb 06, 2023 (PDF 0.9 MB) | Oct 31, 2022 (PDF 0.5 MB) | July 20, 2022 (PDF 0.4 MB)
Latest updates: Investor Update on Access & Sustainability (PDF 1.6 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessment
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Novartis Annual Reporting Suite
Read and download our integrated report, annual regulatory filings, and other disclosures.
Media Releases
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Switzerland